{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:19:15Z","timestamp":1771561155103,"version":"3.50.1"},"reference-count":46,"publisher":"Mark Allen Group","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Nurs"],"published-print":{"date-parts":[[2004,5,1]]},"abstract":"<jats:p>Asthma is a common chronic disease that carries considerable costs both to the individual and to the NHS, despite the availability of effective treatments. All nurses will encounter patients with asthma during their professional careers; therefore, a basic understanding of asthma and its management is required. Asthma responds well to treatment, yet asthma deaths still occur. The variability of asthma symptoms requires the patient to bear the responsibility of disease management from day to day. Patient education is needed if asthma is to be managed well and, while inhaler devices provide an effective delivery system, inhaler technique needs to be taught and devices used correctly if maximum benefit is to be achieved. Personal asthma action plans improve asthma control, yet are currently underused. While compliance with long-term treatment is poor and the reasons for this are complex, understanding some of these reasons and adopting a non-judgmental attitude may reduce frustration among healthcare professionals when managing asthma.<\/jats:p>","DOI":"10.12968\/bjon.2004.13.9.12958","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T14:08:45Z","timestamp":1400854125000},"page":"512-517","source":"Crossref","is-referenced-by-count":10,"title":["An overview of the current asthma disease management guidance"],"prefix":"10.12968","volume":"13","author":[{"given":"Judith","family":"McAllister","sequence":"first","affiliation":[{"name":"Nurse,Greater Peterborough Primary Care Partnership, Peterborough and National Respiratory Training Centre,Warwick"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5130","reference":[{"key":"p_179","volume-title":"Powell","year":"2003"},{"key":"p_180","volume-title":"found that a written action","author":"Gibson","year":"2003"},{"key":"p_206","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70006-5"},{"issue":"4","key":"p_207","first-page":"247","volume":"1","author":"Barnes PJ","year":"1991","journal-title":"Eur Respir Rev"},{"key":"p_208","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.19.2469"},{"key":"p_209","volume-title":"London","author":"British Medical Association","year":"2003"},{"key":"p_210","volume-title":"British National Formulary","author":"British Medical Association\/Royal Pharmaceutical Society of Great Britain","year":"2003"},{"key":"p_211","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/thx.52.2008.S1.5","volume":"52","author":"BTS","year":"1997","journal-title":"Thorax"},{"key":"p_212","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.1.1"},{"key":"p_213","volume-title":"Holding chambers versus nebulisers for beta-agonist treatment of acute asthma (Cochrane Review)","author":"Cates CJ","year":"2001"},{"key":"p_214","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.76.902.767"},{"key":"p_215","volume-title":"London","author":"Do H","year":"2001"},{"key":"p_216","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7344.1003"},{"key":"p_217","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901213400306"},{"key":"p_218","volume-title":"Cochrane Database Syst Rev (1): CD001117","author":"Gibson PG","year":"2003"},{"issue":"2","key":"p_219","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1742-1241.2002.tb11203.x","volume":"56","author":"Gruffyd Jones K","year":"2002","journal-title":"Int J Clin Pract"},{"key":"p_220","volume-title":"Results of a national confidential enquiry into asthma deaths.TheAsthma Journal 5: 180-6","author":"Harrison BDW","year":"2000"},{"key":"p_221","volume-title":"Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma:meta-analysis.BMJ 323: 253-6","author":"Holt S","year":"2001"},{"key":"p_222","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7275.1507"},{"key":"p_223","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04958-8"},{"key":"p_224","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07959-X"},{"key":"p_225","volume-title":"Out in the open.TheAsthma Journal 6(Suppl 3):1-14","author":"NAC","year":"2001"},{"issue":"1","key":"p_226","first-page":"1","volume":"8","author":"Centre","year":"2003","journal-title":"Effective Health Care"},{"key":"p_227","volume-title":"Guidance on the Use of Inhaler Systems (Devices) in Children Under theAge of 5Years with ChronicAsthma.NICE,London","author":"NICE","year":"2000"},{"key":"p_228","volume-title":"London","author":"NICE","year":"2002"},{"key":"p_229","doi-asserted-by":"publisher","DOI":"10.1016\/0271-5384(81)90063-6"},{"key":"p_230","volume-title":"No 6.The Stationery Office","author":"ONS","year":"1998"},{"key":"p_231","volume-title":"No. 26. The Stationery Office","author":"ONS","year":"2000"},{"key":"p_232","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.10.869"},{"key":"p_233","first-page":"299","volume":"50","author":"Paterson C","year":"2000","journal-title":"Br J Gen Pract"},{"key":"p_234","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199711133372001"},{"key":"p_235","volume-title":"Measuring Clinical Outcomes in Asthma","author":"Pearson M","year":"1999"},{"key":"p_236","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.13367399"},{"key":"p_237","volume-title":"Allergy","author":"Platts-Mill TAE","year":"2001","edition":"2"},{"key":"p_238","volume-title":"Cochrane Database Syst Rev (1): CD004107","author":"Powell H","year":"2003"},{"key":"p_239","first-page":"S12","volume":"5","author":"Price D","year":"2000","journal-title":"The Asthma Journal"},{"key":"p_240","first-page":"74","volume":"4","author":"Price D","year":"1999","journal-title":"The Asthma Journal"},{"key":"p_241","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00.16580200"},{"key":"p_242","volume-title":"The natural history of asthma in adults: the problem of irreversibility.JAllergy Clin Immunol 103(4):539-47","author":"Reed CE","year":"1999"},{"key":"p_243","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05113-8"},{"key":"p_244","volume-title":"Annual Report","author":"Royal College of General Practitioners","year":"2000"},{"key":"p_245","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.5.1228"},{"key":"p_246","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7246.1368"},{"key":"p_247","volume-title":"Defining unmet need: relationship between asthma symptoms, asthma-related disability and level of treatment in a nationwide interview survey.The Asthma Journal 5: 136-40","author":"Strachan DP","year":"2000"},{"key":"p_248","volume-title":"Evidence for Action","author":"WHO","year":"2003"},{"key":"p_249","volume-title":"Educational interventions for asthma in children.Cochrane Database Syst Rev (1):CD000326","author":"Wolf FM","year":"2003"}],"container-title":["British Journal of Nursing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/pdf\/10.12968\/bjon.2004.13.9.12958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T11:56:58Z","timestamp":1689249418000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/10.12968\/bjon.2004.13.9.12958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,1]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,5,1]]}},"alternative-id":["10.12968\/bjon.2004.13.9.12958"],"URL":"https:\/\/doi.org\/10.12968\/bjon.2004.13.9.12958","relation":{},"ISSN":["0966-0461","2052-2819"],"issn-type":[{"value":"0966-0461","type":"print"},{"value":"2052-2819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,1]]}}}